Abstract
Over the past decade several research groups have investigated the possible benefits of intraperitoneal chemotherapy in the management of intraabdominal cancers in both an adjuvant setting after resection for cure [1–10] and in an attempt to improve margins of excision following cytoreductive surgery [11–16]. Several important lessons may be learned from these clinical studies, which are relevant to a modern utilization of intraperitoneal chemotherapy. These observations should be used for further improvement of the methodology of chemotherapy delivery into the peritoneal cavity. These methodologic refinements may result in increased survival, alteration of a tumor’s natural history, and improved quality of life of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Koga S, Hamazoe R, Maeta M, et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232–237.
Fujimoto S, Shrestha R, Kokubun M, et al. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far advanced or recurrent gastric cancer. Reg Cancer Treat 1989;2:198–202.
Kokubun M, Fujimoto S, Shrestha R, et al. Intraperitoneal hyperthermic perfusion treatment for patients with gastric cancer and peritoneal dissemination. Reg Cancer Treat 1991;3:316–319.
Schiessel R, Funovics J, Schick B, et al. Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: Results of a randomized trial. JAMA 1989;16: 68–69.
Markman M. Intraperitoneal chemotherapy. Semin Oncol 1991;18:248–254.
Markman M, Reichman B, Hakes T, et al. Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer. J Clin Oncol 1992;10:1479–1484.
Atiq O, Kelsen D, Shiu M, et al. Phase II trial of prospective adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 1993;11:425–433.
Leichman L, Silberman H, Leichman C, et al. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal chemotherapy for gastric cancer: A University of Southern California pilot program. J Clin Oncol 1992;10:1933–1942.
Wansik Y, Sugarbaker P, Ilwoo W. Randomized controlled trial of early postoperative intraperitoneal chemotherapy in gastric cancer: A preliminary report. Reg Cancer Treat, 1994;2:90–93.
Sautner T, Hofbauer F, Depisch D, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long term survival after surgery for advanced gastric cancer. J Clin Oncol 1944;12:970–974.
Sugarbaker P, Graves T, DeBruijn E, et al. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790–5794.
Sugarbaker P, Zhu B, Banez Sese G, Shmookler B. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery with intraperitoneal chemotherapy. Dis Colon Rectum 1993;36:323–329.
Sugarbaker P. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and Sarcomatosis. Dis Colon Rectum 1994;37(Suppl):S115-S122.
Yonemura Y, Fujimura T, Fushida S, et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530–536.
Fujimoto S, Takahashi M, Okui K. A prospective study on combined treatment of intraperitoneal hyperthermic chemotherapy and surgery for patients with refractory gastric cancer. In Taguchi T, Aigner K, eds. Mitomycin C in Cancer Chemotherapy Today. Tokyo: Excerpta Medica, 1991, pp 105–118.
Markman M. Intraperitoneal chemotherapy in the treatment of ovarian cancer. J Infusion Chemother 1993;3:47–49.
Dedrick R. Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 1985;12(Suppl 4):l-6.
Kerr D, Los G. Pharmacokinetic principles of locoregional chemotherapy. Cancer Surv 1993;17:105–122.
Los G, Mutsaers P, Lenglet W, et al. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Phramcol 1990;25:389–394.
Los G, Verdegaal E, Mutsaers P, McVie J. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol 1991;28:159–165.
Panteix G, Guillaumont M, Cherpin L, et al. Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology 1993;50:366–370.
Ozols R, Locker G, Doroshow J, et al. Pharmacokinetics of Adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 1979;39:3209–3214.
Menczer J, Ben-Baruch G, Rizel S, Brenner H. Intraperitoneal chemotherapy versus no treatment in patients with ovarian carcinoma who are in complete clinical remission. Cancer 1992;70:1956–1959.
Markman M, Jones W, Lewis J, et al. Impact of laparotomy finding of significant intra-adbominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy. Cancer Res Clin Oncol 1992;118:163–165.
Markman M, Reichman B, Hakes T, et al. Intraperitoneal chemotherapy in the management of ovarian cancer. Cancer 1993;71:1565–1570.
Osborne R. Future prospects for intraperitoneal therapy of cancer (editorial). Ann Oncol 1994;5:108–110.
Markman M, Reichman M, Hakes T, et al. Responses to second-line cisplatin-based intraperitoneal chemotherapy in ovarian cancer: Influence of prior response to systemic cisplatin. J Clin Oncol 1991;9:1801–1805.
Reichman B, Markman M, Hakes T, et al. Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma. J Clin Oncol 1989;7:1327–1332.
Sugarbaker P, Jablonski K. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221(2):124–132.
Fernandez-Trigo V, Shamsa F, Sugarbaker P. Treatment failures after cytoreductive surgery and intraperitoneal chemotherapy in patients with pseudomyxoma. Acta Chir Austriaca 1995;27:79–83.
Markman M, Hakes T, Reichman B, et al. Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: Influence of increasing the volume of treatment. Gynecol Oncol 1993;49: 185–189.
Esperanca M, Collins D. Peritoneal dialysis efficiency in relation to body weight. J Pediatr Surg 1966;1:162–169.
Cromack D, Cromack T, Pretorius G, DeMeules J. Development of a predictive value equation for the minimum fluid volume to completely coat the intraperitoneal surface in rodents. Surg Forum 1985;36:477–478.
Dedrick R, Zahorko D, Binder R. Pharmacokinetic considerations on resistance to anticancer drugs. Cancer Chemother Rep 1975;59:795–478.
Taylor A, et al. Loculation as a contraindication to intracavitary 32P-chromic phosphate therapy. J Nucl Med 1975;16:318–319.
Vider M, DeLand F, Maruayama Y. Loculation as contraindication to 32P-chromic phosphate therapy. J Nucl Med 1976;17:150–151.
Rosenhein N, Blake D, Mclntyre P, et al. The effect of volume on the distribution of substances instilled into the peritoneal cavity. Gynecol Oncol 1978;6:106–110.
Wahl R, Gyves J, Gross B, et al. SPECT of the peritoneal cavity: Method for delineating intraperitoneal fluid distribution. AJR 1989;152:1205–1210.
Myers M. Peritoneography. Normal and pathologic anatomy. Am J Roentgenol Radiat Ther Nucl Med 1973;117:353–365.
Dunnick N, Jones R, Doppman J, et al. Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics. AJR 1979;1333:221–223.
Hughes P, Zammit-Maempel I, Murthy D, et al. Computed tomographic assessment of intraperitoneal fluid distribution prior to intraperitoneal chemotherapy for ovarian cancer. Br J Radiol 1992;65:295–297.
Giunta S, Tipaldi L, Diotellevi F, et al. CT demonstration of peritoneal metastases after intraperitoneal injection of contrast media. Clin Imaging 1990;14:31–34.
Rundback J, Gray R, Buck D, et al. Fluoroscopically guided peritoneal catheter placement for intraperitoneal chemotherapy. JVIR 1994;5:161–165.
Barlogie B, Corry P, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-platinum and mitomycin C. Cancer Res 1980;40:1165–1168.
Teicher B, Kowal C, Kennedy K, Sartorelli A. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41: 1096–1099.
Wallner K, Li G. Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin C and cisplatin. Cancer Res 1987;47:493–495.
Koga S, Hamazoe R, Maeta M, et al. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 1984;44:1840–1842.
Zoetmulder F. Modelstudies over het Colorectale Carcinoom. Rodopi, Amsterdam, 1982.
Murthy S, Goldsmith R, Rao L, et al. The influence of surgical trauma on experimental metastasis. Cancer 1989;64:2035–2044.
Sweitzer K, Nathanson S, Nelson L, Zashary C. Irrigation does not dislodge or destroy tumor cells adherent to the tumor bed. J Surg Oncol 1993;53:184–190.
Gunduz N, Fisher B, Saffer E. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861–3865.
Fisher B, Gunduz N, Saffer E. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488–1492.
Skipper D, Cooper A, Marston J, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987;74:1049–1052.
Sugarbaker P. Recurrent and advanced primary colorectal cancer: Therapeutic implications of new concepts of gastrointestinal tumor biology. Baillieres Clin Gastroenterol 1989;3: Chapter 10.
Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73:2048–2052.
Jones A, Trott P, Cunningham D, et al. A pilot study of intraperitoneal cisplatin in the management of gastric cancer. Ann Oncol 1994;5:123–126.
Fujimura T, Yonemura Y, Fushida S, et al. Continuous peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65–71.
Shingleton W, Parker R, Mahaley S. Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 1961;50:260–265.
Spratt J, Adcock R, Sherrill W, Travathen S. Hyperthermic peritoneal perfusion system in canines. Cancer Res 1980;40:253–255.
Spratt J, Adcock R, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256–260.
Fujimoto S, Shrestha R, Kokubun M, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding: Ann Surg 1988;208:36–41.
Sugarbaker P. Intraperitoneal Chemotherapy and Cytoreductive Surgery. Manual for Physicians and Nurses. Grand Rapids, MI: Ludann, 1993.
Sugarbaker P. Abdomino-pelvic lavage apparatus and method. U.S. patent number 20531.
Fujimoto S, Takahashi M, Endoh F, et al. A clinical pilot study combining surgery with intraoperative pelvic hyperthermochemotherapy to prevent the local recurrence of rectal cancer. Ann Surg 1991;213:43–47.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Averbach, A.M., Sugarbaker, P.H. (1996). Methodologic considerations in treatment using intraperitoneal chemotherapy. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Principles of Management. Cancer Treatment and Research, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1247-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1247-5_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8531-1
Online ISBN: 978-1-4613-1247-5
eBook Packages: Springer Book Archive